A randomized controlled crossover trial evaluating differential responses to antihypertensive drugs (used as mono- or dual therapy) on the basis of ethnicity: The comparIsoN oF Optimal Hypertension RegiMens; part of the Ancestry Informative Markers in HYpertension program-AIM-HY INFORM trial

    American heart journal, Volume 204, 2018, Pages 102-108.

    Cited by: 1|Bibtex|Views2|Links
    WOS

    Abstract:

    AIM-HY INFORM is a prospective, open-label, randomized trial which aims to evaluate first- and second-line antihypertensive therapies for multiethnic populations.

    Code:

    Data:

    Your rating :
    0

     

    Tags
    Comments